Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.24 -0.06 (-4.58%)
As of: Sep 29, 2026 · 3:50 PM EDT

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Non-Current Debt of $1 million for the year ended Dec 31, 2025.

Analysis

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt (2023 - 2025) Analysis & Trends

  • Annual Non-Current Debt shows a three-year compound annual growth rate of 206.7% (years ended Dec 2022 to Dec 2025).
  • The figure for the year ended Dec 31, 2025 stands as the lowest annual Non-Current Debt since the year ended Dec 31, 2022.
  • Business Quant data shows ZYBT's Non-Current Debt at $34,702 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Zhengye Biotechnology Holding 61.61 Mn 48.99 Mn - 1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Mn
Jun 30, 2025 656,000.00
Dec 31, 2024 668,235.45
Dec 31, 2023 -27,360.82
API Access

Zhengye Biotechnology Holding Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ZYBT&period=max&api_key=YOUR_API_KEY